These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36217342)

  • 1. Multicenter Italian Study on "In Vitro Activities" of Isavuconazole, Voriconazole, Amphotericin B, and Caspofungin for
    Lo Cascio G; Bazaj A; Trovato L; Sanna S; Andreoni S; Blasi E; Conte M; Fazii P; Oliva E; Lepera V; Lombardi G; Farina C
    Infect Drug Resist; 2022; 15():5839-5848. PubMed ID: 36217342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the Sensititre YeastOne and CLSI M38-A2 Microdilution Methods in Determining the Activity of Amphotericin B, Itraconazole, Voriconazole, and Posaconazole against Aspergillus Species.
    Wang HC; Hsieh MI; Choi PC; Wu CJ
    J Clin Microbiol; 2018 Oct; 56(10):. PubMed ID: 30093391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of MIC Test Strip and Sensititre YeastOne with the CLSI and EUCAST Broth Microdilution Reference Methods for
    Delma FZ; Al-Hatmi AMS; Buil JB; van der Lee H; Tehupeiory-Kooreman M; de Hoog GS; Meletiadis J; Verweij PE
    Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 32015025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of a novel broad-spectrum antifungal, E1210, tested against Aspergillus spp. determined by CLSI and EUCAST broth microdilution methods.
    Pfaller MA; Duncanson F; Messer SA; Moet GJ; Jones RN; Castanheira M
    Antimicrob Agents Chemother; 2011 Nov; 55(11):5155-8. PubMed ID: 21844312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro susceptibility of 188 clinical and environmental isolates of Aspergillus flavus for the new triazole isavuconazole and seven other antifungal drugs.
    Shivaprakash MR; Geertsen E; Chakrabarti A; Mouton JW; Meis JF
    Mycoses; 2011 Sep; 54(5):e583-9. PubMed ID: 21518026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of isavuconazole MIC strips for susceptibility testing of Aspergillus and Scedosporium species.
    Trovato L; Scalia G; Palermo CI; Costanzo CM; Oliveri S
    Med Mycol; 2019 Jun; 57(4):429-433. PubMed ID: 30124992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of a custom Sensititre YeastOne plate for susceptibility testing of isavuconazole and other antifungals against clinically relevant yeast and mould species in three Australian diagnostic mycology laboratories.
    Halliday CL; Weeks K; Farac K; Alexiou H; Green W; Lopez R; Sarun Y; Weldhagen GF; Hardiman R; Chen SC; Kidd SE
    Pathology; 2022 Dec; 54(7):922-927. PubMed ID: 35931494
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in
    Espinel-Ingroff A; Turnidge J; Alastruey-Izquierdo A; Botterel F; Canton E; Castro C; Chen YC; Chen Y; Chryssanthou E; Dannaoui E; Garcia-Effron G; Gonzalez GM; Govender NP; Guinea J; Kidd S; Lackner M; Lass-Flörl C; Linares-Sicilia MJ; López-Soria L; Magobo R; Pelaez T; Quindós G; Rodriguez-Iglesia MA; Ruiz MA; Sánchez-Reus F; Sanguinetti M; Shields R; Szweda P; Tortorano A; Wengenack NL; Bramati S; Cavanna C; DeLuca C; Gelmi M; Grancini A; Lombardi G; Meletiadis J; Negri CE; Passera M; Peman J; Prigitano A; Sala E; Tejada M
    Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro susceptibility testing of Aspergillus spp. against voriconazole, itraconazole, posaconazole, amphotericin B and caspofungin.
    Shi JY; Xu YC; Shi Y; Lü HX; Liu Y; Zhao WS; Chen DM; Xi LY; Zhou X; Wang H; Guo LN
    Chin Med J (Engl); 2010 Oct; 123(19):2706-9. PubMed ID: 21034656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multicenter Study of Susceptibility of Aspergillus Species Isolated from Iranian University Hospitals to Seven Antifungal Agents.
    Badiee P; Boekhout T; Zarei Mahmoudabadi A; Mohammadi R; Ayatollahi Mousavi SA; Najafzadeh MJ; Soltani J; Hashemi J; Diba K; Ghadimi-Moghadam A; Salimi-Khorashad AR; Shokohi T; Amin Shahidi M; Ghasemi F; Jafarian H
    Microbiol Spectr; 2022 Jun; 10(3):e0253921. PubMed ID: 35579442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifungal activities of posaconazole, ravuconazole, and voriconazole compared to those of itraconazole and amphotericin B against 239 clinical isolates of Aspergillus spp. and other filamentous fungi: report from SENTRY Antimicrobial Surveillance Program, 2000.
    Pfaller MA; Messer SA; Hollis RJ; Jones RN;
    Antimicrob Agents Chemother; 2002 Apr; 46(4):1032-7. PubMed ID: 11897586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the Etest and the sensititre colorimetric methods with the NCCLS proposed standard for antifungal susceptibility testing of Aspergillus species.
    Meletiadis J; Mouton JW; Meis JF; Bouman BA; Verweij PE
    J Clin Microbiol; 2002 Aug; 40(8):2876-85. PubMed ID: 12149345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [In vitro activity of amphotericin B, itraconazole and voriconazole against 20 species of Aspergillus using the Sensititre microdilution method].
    García-Martos P; García-Agudo L; Gutiérrez-Calzada J; Ruiz-Aragón J; Saldarreaga A; Marín P
    Enferm Infecc Microbiol Clin; 2005 Jan; 23(1):15-8. PubMed ID: 15701327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility to amphotericin B, itraconazole, voriconazole, posaconazole and caspofungin of Aspergillus spp. isolated from patients with haematological malignancies in Tunisia.
    Gheith S; Saghrouni F; Bannour W; Ben Youssef Y; Khelif A; Normand AC; Piarroux R; Ben Said M; Njah M; Ranque S
    Springerplus; 2014; 3():19. PubMed ID: 26034655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the in vitro activity of isavuconazole and comparator voriconazole against 2635 contemporary clinical Candida and Aspergillus isolates.
    Astvad KMT; Hare RK; Arendrup MC
    Clin Microbiol Infect; 2017 Nov; 23(11):882-887. PubMed ID: 28373148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overestimation of Amphotericin B Resistance in Candida auris with Sensititre YeastOne Antifungal Susceptibility Testing: a Need for Adjustment for Correct Interpretation.
    Siopi M; Peroukidou I; Beredaki MI; Spruijtenburg B; de Groot T; Meis JF; Vrioni G; Tsakris A; Pournaras S; Meletiadis J
    Microbiol Spectr; 2023 Jun; 11(3):e0443122. PubMed ID: 37036351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the Sensititre YeastOne colorimetric antifungal panel with a modified NCCLS M38-A method to determine the activity of voriconazole against clinical isolates of Aspergillus spp.
    Castro C; Serrano MC; Flores B; Espinel-Ingroff A; Martín-Mazuelos E
    J Clin Microbiol; 2004 Sep; 42(9):4358-60. PubMed ID: 15365044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antifungal susceptibilities of Aspergillus spp. strains isolated from invasive aspergillosis cases].
    Gürcan S; Tikveşli M; Eryildiz C; Evci C; Ener B
    Mikrobiyol Bul; 2010 Apr; 44(2):273-8. PubMed ID: 20549962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Colistin and Isavuconazole Interact Synergistically In Vitro against
    Schwarz P; Djenontin E; Dannaoui E
    Microorganisms; 2020 Sep; 8(9):. PubMed ID: 32967270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outbreak of Candida auris in Spain: A comparison of antifungal activity by three methods with published data.
    Ruiz-Gaitán AC; Cantón E; Fernández-Rivero ME; Ramírez P; Pemán J
    Int J Antimicrob Agents; 2019 May; 53(5):541-546. PubMed ID: 30769198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.